Contrastingly, Frühbeck et al. demonstrated significant reduced circulating kallistatin in human obesity, and SERPINA4 gene expression levels were downregulated in the liver of obese patients with NAFLD (47). This evidence concerns the gene SERPINA4 and Obesity.